1Fujiwara T, Nishizaki M, Tanaka N. Recombinant adenovirus expressing wild-type P53 is antiangiogenic implication for lung cancer gene therapy. Gan To Kagaku Ryoho, 2000,27(8):1217-1224.
2Koukourakis MI, Giatromanolaki A, O'Byme KJ, et al. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small cell lung cancer. Clin Exp Metast, 1999,17(7):545-554.
3Kakolyris S, Giatromanolaki A, Koukourakis M, et al. Experiment of vascular maturation in non-small lung cancer using a novel basement membrance component, LH39: correlation with P53 and angiogenic factor expression. Cancer Res,1999,59(2):5602-5607.
4Konishi T, Huang CL, Adachi M, et al. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers. Int J Oncol, 2000,16(3):501-511.
5Slodkowska J, Sikora J, Roszkowski S K, et al. Expression of vascular endothelial growth factor and basic fibroblast growth factor receptors in lung cancer. Anal Quant Cytol Histol, 2000,22(5):398-402.
4Gao WM, Mady HH, Yu GY, et al. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung : unique spectra involving G to A transitions and G to T transversions in both histologic types[ J]. Lung Cancer, 2003,40(2 ) : 141-150.
5Dworakowska D, Gozdz S, Jassem E, et al. Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer [ J ]. Lung Cancer, 2002,35 ( 1 ) : 35-41.
6Niklinski J, Niklinska W, Chyczewski L, et al. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications[ J]. Eur J Cancer Prey, 2001,10(3 ) :213-226.
7Swensen S J, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: muhicenter study [ J ]. Radiology, 2000,214 ( 1 ) :73-80.
8Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density [ J ]. Radiology, 2004,233 ( 1 ) : 191-199.
